Author: tkgadmin

The Kinetix Group (TKG) partners with the Ochsner Health Network (OHN) to present the Value Summit 2019

NEW YORK, August 15, 2019 –The Kinetix Group (TKG) is proud to partner with the Ochsner Health Network (OHN) to present the third annual Value Summit on September 19-20, 2019 in New Orleans, with support from AMGA (American Medical Group Association). Registration for the event is now open and open to healthcare professionals.

Univision Joins NASHNET in Advancing Awareness of NASH in Latino Populations

NEW YORK, June 11, 2019 – NASH Network (NASHNET), a global Centers of Excellence Network represented by leading healthcare systems in collaboration with The Kinetix Group, is committed to non-alcoholic steatohepatitis (NASH) care delivery innovation with a mission to create a standard of care for NASH, a high-volume chronic condition.

The Kinetix Group and Consulting at McCann Health’s Research Report on Quality Measures for Nonalcoholic Steatohepatitis (NASH) to Be Presented at ISPOR­ 2019

NEW YORK, March 26, 2019 – The Kinetix Group, in partnership with Consulting at McCann Health, has authored a research report that has been accepted to be exhibited as a poster presentation at ISPOR 2019 in New Orleans on May 20, 2019. The report is titled, “Which Outcome & Quality Measures Do Leading KOLs Who Treat Nonalcoholic Steatohepatitis (NASH) Recommend flor Value-Based Contracting Across Multiple Stakeholders?”, and analyzes primary and secondary research, including insights gathered from 12 US key opinion leaders (KOLs).

The Kinetix Group (TKG) partners with the Ochsner Health Network (OHN) to present the Value Summit 2018 on November 29-30 in New Orleans, LA

NEW YORK, October 30, 2018 – The Kinetix Group (TKG) is proud to partner with the Ochsner Health Network (OHN) to present the second-annual Value Summit on November 29-30, 2018 in New Orleans, with support from the American Medical Group Association (AMGA).

The Kinetix Group Partners with Rimidi to Launch a Clinical Care Partnership for the Management of Nonalcoholic Steatohepatitis (NASH)

NEW YORK, August 30, 2018 – The Kinetix Group in partnership with Rimidi, an Atlanta-based health care technology firm, announced a partnership focused on improving Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) care delivery leveraging NASHNET, a global centers of excellence network.

The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with Echosens Launches a Real World Evidence Model

NEW YORK, August 23, 2018 – The global NASH market is projected to reach $21.5 billion by 2025, with NASH being the leading cause of liver transplantation in the US in the coming years. 1 The NASH Network (NASHNET), in collaboration with The Kinetix Group, has launched a Real World Evidence study to optimize care delivery for patients with Non-Alcoholic Steatohepatitis (NASH).  This initiative is in partnership with Echosens, the innovators and marketers of the FibroScan® family of products.